Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 347 entries
Sorted by: Best Match Show Resources per page
Autism Spectrum Disorders and the Gut Microbiota.

Nutrients

Fattorusso A, Di Genova L, Dell'Isola GB, Mencaroni E, Esposito S.
PMID: 30823414
Nutrients. 2019 Feb 28;11(3). doi: 10.3390/nu11030521.

In recent years, there has been an emerging interest in the possible role of the gut microbiota as a co-factor in the development of autism spectrum disorders (ASDs), as many studies have highlighted the bidirectional communication between the gut...

Cite
Fattorusso A, Di Genova L, Dell'Isola GB, et al. Autism Spectrum Disorders and the Gut Microbiota. Nutrients. 2019;11(3)doi: 10.3390/nu11030521.
Fattorusso, A., Di Genova, L., Dell'Isola, G. B., Mencaroni, E., & Esposito, S. (2019). Autism Spectrum Disorders and the Gut Microbiota. Nutrients, 11(3), . https://doi.org/10.3390/nu11030521
Fattorusso, Antonella, et al. "Autism Spectrum Disorders and the Gut Microbiota." Nutrients vol. 11,3 (2019). doi: https://doi.org/10.3390/nu11030521
Fattorusso A, Di Genova L, Dell'Isola GB, Mencaroni E, Esposito S. Autism Spectrum Disorders and the Gut Microbiota. Nutrients. 2019 Feb 28;11(3). doi: 10.3390/nu11030521. PMID: 30823414; PMCID: PMC6471505.
Copy Download .nbib Format: NLM
Human Gut Microbiome: Function Matters.

Trends in microbiology

Heintz-Buschart A, Wilmes P.
PMID: 29173869
Trends Microbiol. 2018 Jul;26(7):563-574. doi: 10.1016/j.tim.2017.11.002. Epub 2017 Nov 22.

The human gut microbiome represents a complex ecosystem contributing essential functions to its host. Recent large-scale metagenomic studies have provided insights into its structure and functional potential. However, the functional repertoire which is actually contributed to human physiology remains...

Cite
Heintz-Buschart A, Wilmes P. Human Gut Microbiome: Function Matters. Trends Microbiol. 2017;26(7):563-574doi: 10.1016/j.tim.2017.11.002.
Heintz-Buschart, A., & Wilmes, P. (2018). Human Gut Microbiome: Function Matters. Trends in microbiology, 26(7), 563-574. https://doi.org/10.1016/j.tim.2017.11.002
Heintz-Buschart, Anna, and Wilmes, Paul. "Human Gut Microbiome: Function Matters." Trends in microbiology vol. 26,7 (2018): 563-574. doi: https://doi.org/10.1016/j.tim.2017.11.002
Heintz-Buschart A, Wilmes P. Human Gut Microbiome: Function Matters. Trends Microbiol. 2018 Jul;26(7):563-574. doi: 10.1016/j.tim.2017.11.002. Epub 2017 Nov 22. PMID: 29173869.
Copy Download .nbib Format: NLM
Microbiome: Keeping rhythm with your gut.

Nature microbiology

Zhao L, Zhang C.
PMID: 28120934
Nat Microbiol. 2017 Jan 25;2:16273. doi: 10.1038/nmicrobiol.2016.273.

No abstract available.

Cite
Zhao L, Zhang C. Microbiome: Keeping rhythm with your gut. Nat Microbiol. 2017;2:16273doi: 10.1038/nmicrobiol.2016.273.
Zhao, L., & Zhang, C. (2017). Microbiome: Keeping rhythm with your gut. Nature microbiology, 216273. https://doi.org/10.1038/nmicrobiol.2016.273
Zhao, Liping, and Zhang, Chenhong. "Microbiome: Keeping rhythm with your gut." Nature microbiology vol. 2 (2017): 16273. doi: https://doi.org/10.1038/nmicrobiol.2016.273
Zhao L, Zhang C. Microbiome: Keeping rhythm with your gut. Nat Microbiol. 2017 Jan 25;2:16273. doi: 10.1038/nmicrobiol.2016.273. PMID: 28120934.
Copy Download .nbib Format: NLM
The Human Microbiome and Cancer.

Cancer prevention research (Philadelphia, Pa.)

Rajagopala SV, Vashee S, Oldfield LM, Suzuki Y, Venter JC, Telenti A, Nelson KE.
PMID: 28096237
Cancer Prev Res (Phila). 2017 Apr;10(4):226-234. doi: 10.1158/1940-6207.CAPR-16-0249. Epub 2017 Jan 17.

Recent scientific advances have significantly contributed to our understanding of the complex connection between the microbiome and cancer. Our bodies are continuously exposed to microbial cells, both resident and transient, as well as their byproducts, including toxic metabolites. Circulation...

Cite
Rajagopala SV, Vashee S, Oldfield LM, et al. The Human Microbiome and Cancer. Cancer Prev Res (Phila). 2017;10(4):226-234doi: 10.1158/1940-6207.CAPR-16-0249.
Rajagopala, S. V., Vashee, S., Oldfield, L. M., Suzuki, Y., Venter, J. C., Telenti, A., & Nelson, K. E. (2017). The Human Microbiome and Cancer. Cancer prevention research (Philadelphia, Pa.), 10(4), 226-234. https://doi.org/10.1158/1940-6207.CAPR-16-0249
Rajagopala, Seesandra V, et al. "The Human Microbiome and Cancer." Cancer prevention research (Philadelphia, Pa.) vol. 10,4 (2017): 226-234. doi: https://doi.org/10.1158/1940-6207.CAPR-16-0249
Rajagopala SV, Vashee S, Oldfield LM, Suzuki Y, Venter JC, Telenti A, Nelson KE. The Human Microbiome and Cancer. Cancer Prev Res (Phila). 2017 Apr;10(4):226-234. doi: 10.1158/1940-6207.CAPR-16-0249. Epub 2017 Jan 17. PMID: 28096237.
Copy Download .nbib Format: NLM
The Maternal Gut Microbiome During Pregnancy.

MCN. The American journal of maternal child nursing

Edwards SM, Cunningham SA, Dunlop AL, Corwin EJ.
PMID: 28787280
MCN Am J Matern Child Nurs. 2017 Nov/Dec;42(6):310-317. doi: 10.1097/NMC.0000000000000372.

The gut microbiome is a critical component of an individual's metabolism and overall health. The prenatal period is marked by unique inflammatory and immune changes that alter maternal gut function and bacterial composition as the pregnancy advances. The composition...

Cite
Edwards SM, Cunningham SA, Dunlop AL, et al. The Maternal Gut Microbiome During Pregnancy. MCN Am J Matern Child Nurs. 2017;42(6):310-317doi: 10.1097/NMC.0000000000000372.
Edwards, S. M., Cunningham, S. A., Dunlop, A. L., & Corwin, E. J. (2017). The Maternal Gut Microbiome During Pregnancy. MCN. The American journal of maternal child nursing, 42(6), 310-317. https://doi.org/10.1097/NMC.0000000000000372
Edwards, Sara M, et al. "The Maternal Gut Microbiome During Pregnancy." MCN. The American journal of maternal child nursing vol. 42,6 (2017): 310-317. doi: https://doi.org/10.1097/NMC.0000000000000372
Edwards SM, Cunningham SA, Dunlop AL, Corwin EJ. The Maternal Gut Microbiome During Pregnancy. MCN Am J Matern Child Nurs. 2017 Nov/Dec;42(6):310-317. doi: 10.1097/NMC.0000000000000372. PMID: 28787280; PMCID: PMC5648614.
Copy Download .nbib Format: NLM
Depression linked to the microbiome.

Nature medicine

Stower H.
PMID: 30842669
Nat Med. 2019 Mar;25(3):358. doi: 10.1038/s41591-019-0396-4.

No abstract available.

Cite
Stower H. Depression linked to the microbiome. Nat Med. 2019;25(3):358doi: 10.1038/s41591-019-0396-4.
Stower, H. (2019). Depression linked to the microbiome. Nature medicine, 25(3), 358. https://doi.org/10.1038/s41591-019-0396-4
Stower, Hannah. "Depression linked to the microbiome." Nature medicine vol. 25,3 (2019): 358. doi: https://doi.org/10.1038/s41591-019-0396-4
Stower H. Depression linked to the microbiome. Nat Med. 2019 Mar;25(3):358. doi: 10.1038/s41591-019-0396-4. PMID: 30842669.
Copy Download .nbib Format: NLM
[Microbiome & NASH - partners in crime driving progression of fatty liver disease].

Zeitschrift fur Gastroenterologie

Wree A, Geisler LJ, Tacke F.
PMID: 31288283
Z Gastroenterol. 2019 Jul;57(7):871-882. doi: 10.1055/a-0755-2595. Epub 2019 Jul 09.

Along with the increasing prevalence of obesity, metabolic syndrome and type 2 diabetes, non-alcoholic fatty liver disease (NAFLD) is rapidly increasing and poses a major challenge for gastroenterologists. Many studies have demonstrated that the microbiome is closely associated with...

Cite
Wree A, Geisler LJ, Tacke F. Mikrobiom & NASH – enge Komplizen in der Progression von Fettlebererkrankungen. [Microbiome & NASH - partners in crime driving progression of fatty liver disease]. Z Gastroenterol. 2019;57(7):871-882doi: 10.1055/a-0755-2595.
Wree, A., Geisler, L. J., & Tacke, F. (2019). Mikrobiom & NASH – enge Komplizen in der Progression von Fettlebererkrankungen. [Microbiome & NASH - partners in crime driving progression of fatty liver disease]. Zeitschrift fur Gastroenterologie, 57(7), 871-882. https://doi.org/10.1055/a-0755-2595
Wree, Alexander, et al. "Mikrobiom & NASH – enge Komplizen in der Progression von Fettlebererkrankungen." [Microbiome & NASH - partners in crime driving progression of fatty liver disease]. Zeitschrift fur Gastroenterologie vol. 57,7 (2019): 871-882. doi: https://doi.org/10.1055/a-0755-2595
Wree A, Geisler LJ, Tacke F. Mikrobiom & NASH – enge Komplizen in der Progression von Fettlebererkrankungen. [Microbiome & NASH - partners in crime driving progression of fatty liver disease]. Z Gastroenterol. 2019 Jul;57(7):871-882. doi: 10.1055/a-0755-2595. Epub 2019 Jul 09. German. PMID: 31288283.
Copy Download .nbib Format: NLM
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.

Nature reviews. Gastroenterology & hepatology

Wong SH, Yu J.
PMID: 31554963
Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):690-704. doi: 10.1038/s41575-019-0209-8. Epub 2019 Sep 25.

Colorectal cancer (CRC) accounts for about 10% of all new cancer cases globally. Located at close proximity to the colorectal epithelium, the gut microbiota comprises a large population of microorganisms that interact with host cells to regulate many physiological...

Cite
Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16(11):690-704doi: 10.1038/s41575-019-0209-8.
Wong, S. H., & Yu, J. (2019). Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nature reviews. Gastroenterology & hepatology, 16(11), 690-704. https://doi.org/10.1038/s41575-019-0209-8
Wong, Sunny H, and Yu, Jun. "Gut microbiota in colorectal cancer: mechanisms of action and clinical applications." Nature reviews. Gastroenterology & hepatology vol. 16,11 (2019): 690-704. doi: https://doi.org/10.1038/s41575-019-0209-8
Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):690-704. doi: 10.1038/s41575-019-0209-8. Epub 2019 Sep 25. PMID: 31554963.
Copy Download .nbib Format: NLM
[Research progress of gut microbiota and microbiota-targeted therapy in critical ill patients].

Zhonghua wei zhong bing ji jiu yi xue

Xu R, Tan C, Yin J, Pan S.
PMID: 30541654
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Nov;30(11):1099-1102. doi: 10.3760/cma.j.issn.2095-4352.2018.011.018.

OBJECTIVE: In physiological conditions, a diverse microbiota might enhance host defense. However, the gut microbiota of critically ill patients is characterized by lower diversity, lower abundances of key commensal genera, and overgrowth by one bacterial generation, a state known...

Cite
Xu R, Tan C, Yin J, et al. [Research progress of gut microbiota and microbiota-targeted therapy in critical ill patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30(11):1099-1102doi: 10.3760/cma.j.issn.2095-4352.2018.011.018.
Xu, R., Tan, C., Yin, J., & Pan, S. (2018). [Research progress of gut microbiota and microbiota-targeted therapy in critical ill patients]. Zhonghua wei zhong bing ji jiu yi xue, 30(11), 1099-1102. https://doi.org/10.3760/cma.j.issn.2095-4352.2018.011.018
Xu, Ruoting, et al. "[Research progress of gut microbiota and microbiota-targeted therapy in critical ill patients]." Zhonghua wei zhong bing ji jiu yi xue vol. 30,11 (2018): 1099-1102. doi: https://doi.org/10.3760/cma.j.issn.2095-4352.2018.011.018
Xu R, Tan C, Yin J, Pan S. [Research progress of gut microbiota and microbiota-targeted therapy in critical ill patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Nov;30(11):1099-1102. doi: 10.3760/cma.j.issn.2095-4352.2018.011.018. Chinese. PMID: 30541654.
Copy Download .nbib Format: NLM
Up-close-and-personal with the human microbiome.

Environmental microbiology reports

Berry D.
PMID: 30431239
Environ Microbiol Rep. 2019 Feb;11(1):17-19. doi: 10.1111/1758-2229.12709. Epub 2018 Nov 15.

No abstract available.

Cite
Berry D. Up-close-and-personal with the human microbiome. Environ Microbiol Rep. 2018;11(1):17-19doi: 10.1111/1758-2229.12709.
Berry, D. (2019). Up-close-and-personal with the human microbiome. Environmental microbiology reports, 11(1), 17-19. https://doi.org/10.1111/1758-2229.12709
Berry, David. "Up-close-and-personal with the human microbiome." Environmental microbiology reports vol. 11,1 (2019): 17-19. doi: https://doi.org/10.1111/1758-2229.12709
Berry D. Up-close-and-personal with the human microbiome. Environ Microbiol Rep. 2019 Feb;11(1):17-19. doi: 10.1111/1758-2229.12709. Epub 2018 Nov 15. PMID: 30431239.
Copy Download .nbib Format: NLM
Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy.

Journal of gastrointestinal cancer

Joukar F, Mavaddati S, Mansour-Ghanaei F, Samadani AA.
PMID: 31025167
J Gastrointest Cancer. 2020 Jun;51(2):363-378. doi: 10.1007/s12029-019-00237-6.

Cancer therapeutic methods comprising chemotherapy, radiotherapy, and surgery are so routine in cancer treatment. Remarkably, there are several personal features which affect the effectiveness of such treatments including nutrition, microbiome diversity, and physical activity which has distinct significant roles...

Cite
Joukar F, Mavaddati S, Mansour-Ghanaei F, et al. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy. J Gastrointest Cancer. 2020;51(2):363-378doi: 10.1007/s12029-019-00237-6.
Joukar, F., Mavaddati, S., Mansour-Ghanaei, F., & Samadani, A. A. (2020). Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy. Journal of gastrointestinal cancer, 51(2), 363-378. https://doi.org/10.1007/s12029-019-00237-6
Joukar, Farahnaz, et al. "Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy." Journal of gastrointestinal cancer vol. 51,2 (2020): 363-378. doi: https://doi.org/10.1007/s12029-019-00237-6
Joukar F, Mavaddati S, Mansour-Ghanaei F, Samadani AA. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy. J Gastrointest Cancer. 2020 Jun;51(2):363-378. doi: 10.1007/s12029-019-00237-6. PMID: 31025167.
Copy Download .nbib Format: NLM
More Than Meets the Eye: Our Microbiome May Be Key to Decreasing Infection.

Genetic testing and molecular biomarkers

Wurst T, Terry S.
PMID: 31050571
Genet Test Mol Biomarkers. 2019 May;23(5):297-298. doi: 10.1089/gtmb.2019.29046.sjt.

No abstract available.

Cite
Wurst T, Terry S. More Than Meets the Eye: Our Microbiome May Be Key to Decreasing Infection. Genet Test Mol Biomarkers. 2019;23(5):297-298doi: 10.1089/gtmb.2019.29046.sjt.
Wurst, T., & Terry, S. (2019). More Than Meets the Eye: Our Microbiome May Be Key to Decreasing Infection. Genetic testing and molecular biomarkers, 23(5), 297-298. https://doi.org/10.1089/gtmb.2019.29046.sjt
Wurst, Tamara, and Terry, Sharon. "More Than Meets the Eye: Our Microbiome May Be Key to Decreasing Infection." Genetic testing and molecular biomarkers vol. 23,5 (2019): 297-298. doi: https://doi.org/10.1089/gtmb.2019.29046.sjt
Wurst T, Terry S. More Than Meets the Eye: Our Microbiome May Be Key to Decreasing Infection. Genet Test Mol Biomarkers. 2019 May;23(5):297-298. doi: 10.1089/gtmb.2019.29046.sjt. PMID: 31050571.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 347 entries